A single dose, globally accessible vaccine to combat emerging SARS-CoV-2 variants

  • Funded by National Health and Medical Research Council (NHMRC)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    N/A
  • Known Financial Commitments (USD)

    $1,220,187.38
  • Funder

    National Health and Medical Research Council (NHMRC)
  • Research Location

    Australia
  • Lead Research Institution

    University of Sydney
  • Research Priority Alignment

    N/A
  • Research Category

    Vaccines research, development and implementation
  • Research Subcategory

    Pre-clinical studies
  • Special Interest Tags

    N/A
  • Study Type

    Unspecified
  • Clinical Trial Details

    N/A
  • Broad Policy Alignment

    Pending
  • Age Group

    Unspecified
  • Vulnerable Population

    Unspecified
  • Occupations of Interest

    Unspecified

Abstract